• SENSEX 73,033.78
    1,109.10 (+1.54%)
  • BANKNIFTY 55,481.05
    563.05 (+1.03%)
Back

Corporate News

Oxygenta Pharmaceutical furnished dematerialization details to BSE Limited, per regulatory requirements
13-Oct-2026, 03:06

Oxygenta Pharmaceutical Ltd (Scrip Code: 524636) reported that details of securities dematerialized during the quarter ended September 30, 2026, have been furnished to stock exchanges as required under Regulation 74(5) of the SEBI [Depositories and Participants] Regulations, 2018, according to a filing with the BSE Limited on October 13, 2026, referencing a letter from M/s. Venture Capital and Corporate Investments Private Limited dated October 5, 2026.